{"id":110938,"date":"2025-12-19T10:22:13","date_gmt":"2025-12-19T10:22:13","guid":{"rendered":"https:\/\/www.europesays.com\/se\/110938\/"},"modified":"2025-12-19T10:22:13","modified_gmt":"2025-12-19T10:22:13","slug":"hpv-vaccin-skyddar-aven-mot-andra-cellforandringar","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/110938\/","title":{"rendered":"Hpv-vaccin skyddar \u00e4ven mot andra cellf\u00f6r\u00e4ndringar"},"content":{"rendered":"<p><img width=\"644\" height=\"888\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/12\/JiayaoLei_portr.jpg\" class=\"attachment-original size-original\" alt=\"\" decoding=\"async\" fetchpriority=\"high\"  \/><\/p>\n<p>Jiayao Lei. Foto: Privat.<\/p>\n<p><img loading=\"lazy\" width=\"1154\" height=\"1592\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/12\/YunyangDeng_fotoGunillaSonnebring_portr.jpg\" class=\"attachment-original size-original\" alt=\"\" decoding=\"async\"  \/><\/p>\n<p>Yunyang Deng. Foto: Gunilla Sonnebring.<\/p>\n<p>Hpv-vaccin skyddar flickor och kvinnor inte bara mot livmoderhalscancer, utan \u00e4ven mot\u00a0allvarliga cellf\u00f6r\u00e4ndringar i vulva och vagina,. Det g\u00e4ller s\u00e4rskilt om man f\u00e5r vaccin f\u00f6re 17 \u00e5rs \u00e5lder. Det visar en ny studie fr\u00e5n Karolinska institutet som publicerats i tidskriften <a href=\"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2843054\" rel=\"nofollow noopener\" target=\"_blank\">Jama oncology<\/a>.<\/p>\n<p><strong>I Sverige erbjuds<\/strong> alla barn i \u00e5rskurs 5 vaccination mot humant papillomvirus, hpv, som bland annat skyddar mot livmoderhalscancer och peniscancer. Hpv-infektion kan \u00e4ven orsaka cellf\u00f6r\u00e4ndringar och cancer i andra delar av underlivet. I den nya studien visar forskarna att det fyravalenta hpv-vaccinet, som skyddar mot hpv-typerna 6, 11, 16 och 18, kan kopplas till minskad risk f\u00f6r allvarliga cellf\u00f6r\u00e4ndringar i vulva och vagina.<\/p>\n<p>Tidigt hpv-vaccin skyddar b\u00e4st<\/p>\n<p>Studien bygger p\u00e5 data om 778\u202f 943 kvinnor f\u00f6dda mellan 1985 och 1998. Forskarna anv\u00e4nde svenska h\u00e4lsoregister f\u00f6r att f\u00f6lja deltagarna \u00f6ver tid. De j\u00e4mf\u00f6rde f\u00f6rekomsten av h\u00f6ggradiga cellf\u00f6r\u00e4ndringar i vulva och vagina hos kvinnor som f\u00e5tt minst en dos av hpv-vaccinet och kvinnor som inte vaccinerats.<\/p>\n<p><strong>Resultaten visar att<\/strong> risken f\u00f6r allvarliga cellf\u00f6r\u00e4ndringar var 37 procent l\u00e4gre hos vaccinerade kvinnor \u00e4n hos med ovaccinerade, efter justering f\u00f6r faktorer som \u00e5lder, utbildning, inkomst och moderns sjukdomshistoria. Skyddet var starkast hos kvinnor som f\u00e5tt vaccin f\u00f6re 17 \u00e5rs \u00e5lder. De hade 55 procent l\u00e4gre risk \u00e4n ovaccinerade j\u00e4mn\u00e5riga.<\/p>\n<p>\u2013 V\u00e5r studie \u00e4r den st\u00f6rsta i sitt slag som unders\u00f6ker sambandet mellan hpv-vaccination och allvarliga sjukdomar i vulva och vagina. Resultaten understryker vikten av att erbjuda vaccination tidigt i livet, innan sexuell debut, s\u00e4ger Yunyang Deng, postdoktor vid institutionen f\u00f6r medicinsk epidemiologi och biostatistik, Karolinska institutet, i ett <a href=\"https:\/\/nyheter.ki.se\/hpv-vaccin-kan-skydda-mot-cellforandringar-i-vulva-och-vagina\" rel=\"nofollow noopener\" target=\"_blank\">pressmeddelande<\/a>.<\/p>\n<p>Vill studera andra cancerformer<\/p>\n<p>Forskarna planerar nu att unders\u00f6ka hur effektiva olika typer av hpv-vaccin \u00e4r, och hur l\u00e4nge skyddet fr\u00e5n vaccinet kan vara.<\/p>\n<p><strong>\u2013 Vi vill ocks\u00e5<\/strong> studera vaccinets effekt mot andra hpv-relaterade cancerformer, \u00e4ven hos m\u00e4n, s\u00e4ger Jiayao Lei, bitr\u00e4dande lektor vid samma institution, som lett studien.<\/p>\n","protected":false},"excerpt":{"rendered":"Jiayao Lei. Foto: Privat. Yunyang Deng. Foto: Gunilla Sonnebring. Hpv-vaccin skyddar flickor och kvinnor inte bara mot livmoderhalscancer,&hellip;\n","protected":false},"author":2,"featured_media":110939,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,446,34,31,33,32,30],"class_list":{"0":"post-110938","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-karolinska-institutet","11":"tag-se","12":"tag-svenska","13":"tag-sverige","14":"tag-sweden","15":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115745741204583912","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/110938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=110938"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/110938\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/110939"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=110938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=110938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=110938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}